Aprea Therapeutics, Inc.

NasdaqCM:APRE Stock Report

Market Cap: US$8.9m

Aprea Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:APRE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Apr 25BuyUS$10,110Oren GiladIndividual5,500US$1.87
23 Oct 24BuyUS$1,958Oren GiladIndividual500US$3.92
18 Oct 24SellUS$29,583Marc DueyIndividual6,462US$4.58
16 Oct 24BuyUS$131,700Marc DueyIndividual30,000US$4.39
15 Oct 24BuyUS$725Oren GiladIndividual250US$2.90
14 Oct 24BuyUS$2,971Oren GiladIndividual1,150US$2.59
14 Oct 24BuyUS$490Marc DueyIndividual190US$2.58
11 Oct 24BuyUS$26,800Bernd SeizingerIndividual10,000US$2.68
11 Oct 24BuyUS$123John HamillIndividual50US$2.46
10 Oct 24BuyUS$1,175John HamillIndividual450US$2.61

Insider Trading Volume

Insider Buying: APRE insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of APRE?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms539,3009.82%
Individual Insiders650,14011.8%
Hedge Funds859,60315.7%
Institutions992,35518.1%
General Public2,450,55544.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 55.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
Sphera Funds Management Ltd
583,000US$944.5k116%0.16%
9.82%
Aigh Capital Management, LLC
539,300US$873.7k0%0.42%
6.07%
Oren Gilad
333,189US$539.8k2.8%no data
5.04%
Sio Capital Management, LLC
276,603US$448.1k0%0.16%
4.25%
Marc Duey
233,208US$377.8k0%no data
3.75%
Nantahala Capital Management, LLC
205,760US$333.3k0%0.03%
3.17%
The Vanguard Group, Inc.
173,842US$281.6k0%no data
2.72%
Stonepine Capital Management LLC
149,221US$241.7k8.78%0.11%
2.5%
Dafna Capital Management, LLC
137,174US$222.2k0%0.07%
2.33%
Exome Asset Management LLC
127,960US$207.3k-6.72%0.18%
0.8%
Bernd Seizinger
43,685US$70.8k0%no data
0.78%
Geode Capital Management, LLC
42,663US$69.1k6.48%no data
0.67%
Morgan Stanley, Investment Banking and Brokerage Investments
36,808US$59.6k7.6%no data
0.64%
Landscape Capital Management, LLC
35,328US$57.2k0%0.01%
0.32%
Rifat Pamukcu
17,464US$28.3k2.95%no data
0.31%
Dimensional Fund Advisors LP
17,064US$27.6k0%no data
0.29%
LPL Financial Corporation, Asset Management Arm
16,052US$26.0k0%no data
0.25%
HighTower Advisors, LLC
13,864US$22.5k0%no data
0.24%
BNP Paribas Arbitrage Sa, Asset Management Arm
13,011US$21.1k0%no data
0.23%
John Hamill
12,627US$20.5k80.2%no data
0.15%
BlackRock, Inc.
8,504US$13.8k0%no data
0.15%
John Henneman
8,139US$13.2k6.55%no data
0.11%
UBS Asset Management AG
5,935US$9.6k198,000%no data
0.059%
Merrill Lynch & Co. Inc., Banking Investments
3,250US$5.3k0%no data
0.029%
Bank of America Corporation, Asset Management Arm
1,601US$2.6k-0.06%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 11:26
End of Day Share Price 2025/05/12 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aprea Therapeutics, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Esther Lannie HongBerenberg
Joseph PantginisH.C. Wainwright & Co.
Jason McCarthyMaxim Group